Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 51 to 75 of about 5967

Previous 25

Website Changes

08/18/2025

Social Security makes a big change to eligibility rules

08/18/2025

Upcoming webinar!

08/11/2025

March On for Brain Injury - Long Island Walk

08/10/2025

Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial

08/06/2025

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

08/06/2025

Musella Foundation Copay Program now closed to new and renewal applicants

08/04/2025

Bevacizumab alternating chemotherapy for improving the survival of patients with recurrent high-grade glioma

08/04/2025

Dana-Farber Research Shows Promise for Targeted Therapies for Pediatric Gliomas

08/04/2025

Musella Foundation Copay Program Almost Closed

07/21/2025

Collaboration in US and Global Fight Against Cancer

07/21/2025

BCSSA Nurse Navigator featured on Rare Enough Podcast

07/14/2025

4th Annual Tumor Takedown Event

07/14/2025

Weill Cornell Medicine Research Team Awarded Grant to Advance Promising Brain Cancer Therapy Using Focused Ultrasound and ThermoDox®

07/14/2025

A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen

07/14/2025

New MRI approach maps brain metabolism, revealing disease signatures

07/14/2025

Glioblastoma Caregiver Virtual Discussion

07/01/2025

Copayment assistance program is now open!

06/25/2025

Tonight`s webinar is POSTPONED

06/23/2025

Reminder - Webinar on Wednesday!

06/23/2025

Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma

06/16/2025

Upcoming webinar!

06/15/2025

College Scholarship for Brain Cancer Families

06/09/2025

Phase II propensity-matched controlled trial evaluating metformin as an adjunct to neoadjuvant, concomitant, and adjuvant temozolomide and hypofractionated accelerated radiotherapy (M-HART) in glioblastoma patients (NCT02780024)

06/09/2025

FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields

06/09/2025

Dual-Target CAR T-Cell Therapy Slows Glioblastoma Growth

Our privacy / cookie policy has changed.
Click HERE to read it!